<p>优莎娜（NYSE:USNA - 获取免费报告）在周五发布的报告中被 DA Davidson 的研究分析师上调至 “持有” 评级，Zacks.com 报道。</p>
<p>获取 <strong>优莎娜</strong> 的提醒：</p>
<p>另外，StockNews.com 在周四的研究报告中将优莎娜的股票评级从 “买入” 上调至 “强力买入”。</p>
<p><strong>获取我们关于 USNA 的最新股票报告</strong></p>
<h2>优莎娜股价下跌 3.8%</h2>
<p>周五交易时段，USNA 的股票下跌 1.33 美元，达到 33.38 美元。该公司交易了 619,779 股，较其平均交易量 84,047 股有所增加。该股票的 50 日移动平均价格为 37.96 美元，200 日移动平均价格为 40.47 美元。优莎娜的 12 个月低点为 33.28 美元，12 个月高点为 54.81 美元。该公司的市值为 6.3622 亿美元，市盈率为 11.80，PEG 比率为 1.25，贝塔值为 0.89。</p>
<p>优莎娜（NYSE:USNA - 获取免费报告）最近于 10 月 22 日发布了季度财报。公司报告季度每股收益为 0.56 美元，超出市场共识预期的 0.49 美元，超出幅度为 0.07 美元。优莎娜的股本回报率为 10.64%，净利润率为 6.30%。该季度公司的收入为 2.0022 亿美元，而市场共识预期为 2.0845 亿美元。去年同期，该公司每股收益为 0.59 美元。研究分析师平均预测优莎娜在当前年度的每股收益为 2.45 美元。</p>
<h2>内部买卖</h2>
<p>在其他优莎娜的新闻中，董事 Gilbert A. Fuller 于 11 月 4 日星期一出售了 675 股股票。该股票以平均价格 37.71 美元出售，总交易额为 25,454.25 美元。此次出售在向 SEC 的备案中披露，相关文件可通过此链接获取。公司内部人士持有该公司股票的 0.33%。</p>
<h2>优莎娜的机构交易</h2>
<p>一些对冲基金最近增加或减少了在 USNA 的持股。Safe Harbor Fiduciary LLC 在第三季度购买了优莎娜的新头寸，价值约 30,000 美元。KBC Group NV 在第三季度将其在优莎娜的持股增加了 96.6%。KBC Group NV 现在拥有 1,056 股该公司的股票，价值 40,000 美元，此前在该期间内又购买了 519 股。Centiva Capital LP 在第三季度购买了优莎娜的新股份，价值 213,000 美元。BOKF NA 在第二季度将其在优莎娜的持股增加了 99.4%。BOKF NA 现在拥有 5,526 股该公司的股票，价值 250,000 美元，此前在上个季度又购买了 2,755 股。最后，Quest Partners LLC 在第三季度收购了优莎娜的股份，价值约 250,000 美元。54.25% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>优莎娜公司简介</h2>
<p>（获取免费报告）</p>
<p>优莎娜健康科学公司在亚太地区、美洲和欧洲开发、制造和销售基于科学的营养、个人护理和护肤产品。该公司提供的优莎娜营养产品包括基础营养/CellSentials，如提供各种年龄段全面营养的维生素和矿物质补充剂；优化剂，包括旨在满足心血管、骨骼/结构和消化健康需求的针对性补充剂；以及包括餐替代奶昔、零食棒和其他相关产品的食品。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，优莎娜不在其中</li>
<li>资产配置：成功投资组合的关键。你在关注自己的投资组合吗？</li>
<li>石油巨头对决：埃克森美孚还是雪佛龙，谁能在 2025 年获利？</li>
<li>如何投资生物科技股票</li>
<li>矿业股票再次成为焦点：3 个关键名字值得关注</li>
<li>今日最大股票亏损者 - 今日最大百分比下跌者</li>
<li>MarketBeat 周回顾 – 12/16 - 12/20</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<p>→ 紧急：这个山寨币机会不会等你 – 立即行动（来自加密交换利润）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDk4NQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDk4NQ"/></p>
<h2>你现在应该投资 1,000 美元在优莎娜吗？</h2>
<p>在考虑优莎娜之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在就买入，以便在更广泛的市场注意到之前……而优莎娜并不在名单上。</p>
<p>虽然优莎娜目前在分析师中被评为 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

优莎娜

<p>DA Davidson 将优莎娜 (NYSE:USNA) 的评级上调至 “持有”。该股票在周五下跌了 3.8%，达到 0.38 美元。优莎娜的 12 个月低点为 0.28 美元，高点为 0.81 美元。公司报告的每股收益为 0.56 美元，超出预期。内部交易方面，董事 Gilbert A. Fuller 出售了 675 股。对冲基金持有该股票的 54.25%。优莎娜在全球范围内开发和销售营养及个人护理产品</p>

<p>USANA Health Sciences (NYSE:USNA - Get Free Report) was upgraded by research analysts at DA Davidson to a &#34;hold&#34; rating in a report issued on Friday,Zacks.com reports.</p>
<div class="lb-trans"><p>优莎娜（NYSE:USNA - 获取免费报告）在周五发布的报告中被 DA Davidson 的研究分析师上调至 “持有” 评级，Zacks.com 报道。</p>
</div><p>Get <strong>USANA Health Sciences</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>优莎娜</strong> 的提醒：</p>
</div><p>Separately, StockNews.com upgraded shares of USANA Health Sciences from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a research note on Thursday.</p>
<div class="lb-trans"><p>另外，StockNews.com 在周四的研究报告中将优莎娜的股票评级从 “买入” 上调至 “强力买入”。</p>
</div><p><strong>Get Our Latest Stock Report on USNA</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 USNA 的最新股票报告</strong></p>
</div><h2>USANA Health Sciences Trading Down 3.8 %</h2>
<div class="lb-trans"><h2>优莎娜股价下跌 3.8%</h2>
</div><p>Shares of USNA traded down $1.33 during trading hours on Friday, reaching $33.38. 619,779 shares of the company traded hands, compared to its average volume of 84,047. The stock's fifty day moving average price is $37.96 and its 200 day moving average price is $40.47. USANA Health Sciences has a 12-month low of $33.28 and a 12-month high of $54.81. The firm has a market cap of $636.22 million, a price-to-earnings ratio of 11.80, a PEG ratio of 1.25 and a beta of 0.89.</p>
<div class="lb-trans"><p>周五交易时段，USNA 的股票下跌 1.33 美元，达到 33.38 美元。该公司交易了 619,779 股，较其平均交易量 84,047 股有所增加。该股票的 50 日移动平均价格为 37.96 美元，200 日移动平均价格为 40.47 美元。优莎娜的 12 个月低点为 33.28 美元，12 个月高点为 54.81 美元。该公司的市值为 6.3622 亿美元，市盈率为 11.80，PEG 比率为 1.25，贝塔值为 0.89。</p>
</div><p>USANA Health Sciences (NYSE:USNA - Get Free Report) last released its quarterly earnings data on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, topping the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The company had revenue of $200.22 million for the quarter, compared to the consensus estimate of $208.45 million. During the same period last year, the business posted $0.59 EPS. On average, research analysts forecast that USANA Health Sciences will post 2.45 earnings per share for the current year.</p>
<div class="lb-trans"><p>优莎娜（NYSE:USNA - 获取免费报告）最近于 10 月 22 日发布了季度财报。公司报告季度每股收益为 0.56 美元，超出市场共识预期的 0.49 美元，超出幅度为 0.07 美元。优莎娜的股本回报率为 10.64%，净利润率为 6.30%。该季度公司的收入为 2.0022 亿美元，而市场共识预期为 2.0845 亿美元。去年同期，该公司每股收益为 0.59 美元。研究分析师平均预测优莎娜在当前年度的每股收益为 2.45 美元。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><p>In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of the stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $37.71, for a total transaction of $25,454.25. The sale was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.33% of the company's stock.</p>
<div class="lb-trans"><p>在其他优莎娜的新闻中，董事 Gilbert A. Fuller 于 11 月 4 日星期一出售了 675 股股票。该股票以平均价格 37.71 美元出售，总交易额为 25,454.25 美元。此次出售在向 SEC 的备案中披露，相关文件可通过此链接获取。公司内部人士持有该公司股票的 0.33%。</p>
</div><h2>Institutional Trading of USANA Health Sciences</h2>
<div class="lb-trans"><h2>优莎娜的机构交易</h2>
</div><p>A number of hedge funds have recently added to or reduced their stakes in USNA. Safe Harbor Fiduciary LLC purchased a new position in USANA Health Sciences during the third quarter worth approximately $30,000. KBC Group NV grew its stake in USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company's stock valued at $40,000 after acquiring an additional 519 shares during the period. Centiva Capital LP purchased a new stake in USANA Health Sciences in the 3rd quarter worth $213,000. BOKF NA lifted its holdings in USANA Health Sciences by 99.4% during the second quarter. BOKF NA now owns 5,526 shares of the company's stock valued at $250,000 after purchasing an additional 2,755 shares in the last quarter. Finally, Quest Partners LLC acquired a new stake in shares of USANA Health Sciences in the third quarter valued at about $250,000. 54.25% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>一些对冲基金最近增加或减少了在 USNA 的持股。Safe Harbor Fiduciary LLC 在第三季度购买了优莎娜的新头寸，价值约 30,000 美元。KBC Group NV 在第三季度将其在优莎娜的持股增加了 96.6%。KBC Group NV 现在拥有 1,056 股该公司的股票，价值 40,000 美元，此前在该期间内又购买了 519 股。Centiva Capital LP 在第三季度购买了优莎娜的新股份，价值 213,000 美元。BOKF NA 在第二季度将其在优莎娜的持股增加了 99.4%。BOKF NA 现在拥有 5,526 股该公司的股票，价值 250,000 美元，此前在上个季度又购买了 2,755 股。最后，Quest Partners LLC 在第三季度收购了优莎娜的股份，价值约 250,000 美元。54.25% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>USANA Health Sciences Company Profile</h2>
<div class="lb-trans"><h2>优莎娜公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.</p>
<div class="lb-trans"><p>优莎娜健康科学公司在亚太地区、美洲和欧洲开发、制造和销售基于科学的营养、个人护理和护肤产品。该公司提供的优莎娜营养产品包括基础营养/CellSentials，如提供各种年龄段全面营养的维生素和矿物质补充剂；优化剂，包括旨在满足心血管、骨骼/结构和消化健康需求的针对性补充剂；以及包括餐替代奶昔、零食棒和其他相关产品的食品。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than USANA Health Sciences</li>
<li>Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?</li>
<li>Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?</li>
<li>How to Invest in Biotech Stocks</li>
<li>Mining Stocks Back in the Spotlight: 3 Key Names to Watch</li>
<li>Biggest Stock Losers - Today’s Biggest Percentage Decliners</li>
<li>MarketBeat Week in Review – 12/16 - 12/20</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，优莎娜不在其中</li>
<li>资产配置：成功投资组合的关键。你在关注自己的投资组合吗？</li>
<li>石油巨头对决：埃克森美孚还是雪佛龙，谁能在 2025 年获利？</li>
<li>如何投资生物科技股票</li>
<li>矿业股票再次成为焦点：3 个关键名字值得关注</li>
<li>今日最大股票亏损者 - 今日最大百分比下跌者</li>
<li>MarketBeat 周回顾 – 12/16 - 12/20</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><p>→ URGENT: This Altcoin Opportunity Won’t Wait – Act Now (From Crypto Swap Profits)(Ad)</p>
<div class="lb-trans"><p>→ 紧急：这个山寨币机会不会等你 – 立即行动（来自加密交换利润）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDk4NQ" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10985&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in USANA Health Sciences right now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在优莎娜吗？</h2>
</div><p>Before you consider USANA Health Sciences, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑优莎娜之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在就买入，以便在更广泛的市场注意到之前……而优莎娜并不在名单上。</p>
</div><p>While USANA Health Sciences currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然优莎娜目前在分析师中被评为 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

优莎娜健康科学公司 (NYSE:USNA) 被 DA Davidson 上调至持有评级